FibroBiologics, Inc.
FBLGNasdaqCIK 1958777HealthcareFiscal year ends Dec 31
Reports and events: 87 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0821:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-418065 |
| 2026-09-1820:05 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-395511 |
| 2026-09-1720:01 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-26-043112 |
| 2026-09-1511:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-391310 |
| 2026-08-2412:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-362027 |
| 2026-07-3120:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-328454 |
| 2026-07-3113:14 ET | DEF 14A | Proxy statementPeriod 2026-09-17 | 0001193125-26-326818 |
| 2026-07-2420:05 ET | 8-K | 3.01 Delisting notice | 0001193125-26-316067 |
| 2026-07-0913:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-299290 |
| 2026-06-2920:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-288468 |
| 2026-06-2321:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-279778 |
| 2026-05-0611:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-207530 |
| 2026-05-0511:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-205044 |
| 2026-05-0511:18 ET | DEF 14A | Proxy statementPeriod 2026-05-05 | 0001193125-26-205032 |
| 2026-05-0120:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-201376 |
| 2026-04-3021:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-197858 |
| 2026-04-2020:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164018 |
| 2026-04-1720:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-161507 |
| 2026-04-0921:20 ET | 8-K/A | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149865 |
| 2026-04-0920:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149654 |
| 2026-04-0320:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-142089 |
| 2026-04-0220:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-140044 |
| 2026-03-2721:19 ET | S-1 | Registration statement | 0001493152-26-013274 |
| 2026-03-1320:20 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-106216 |
| 2026-03-0621:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-096474 |
| 2026-02-2421:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-066965 |
| 2026-02-2321:18 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-064040 |
| 2026-02-0621:10 ET | 8-K | 3.01 Delisting notice | 0001193125-26-041187 |
| 2026-01-0222:15 ET | 8-K | 3.01 Delisting notice | 0001193125-26-001077 |
| 2025-12-2914:31 ET | DEF 14A | Proxy statementPeriod 2026-02-20 | 0001193125-25-332248 |
| 2025-12-2321:02 ET | S-1 | Registration statement | 0001493152-25-029010 |
| 2025-12-1811:37 ET | DEF 14A | Proxy statementPeriod 2025-12-18 | 0001193125-25-323667 |
| 2025-12-1522:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-25-319441 |
| 2025-11-2513:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure | 0001193125-25-294634 |
| 2025-11-1921:53 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-288264 |
| 2025-10-3120:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-260774 |
| 2025-08-0820:05 ET | 8-K | 3.01 Delisting notice | 0000950170-25-105807 |
| 2025-07-3120:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-100917 |
| 2025-07-1820:08 ET | 8-K/A | 3.02 Unregistered sale of equity | 0000950170-25-096923 |
| 2025-07-1820:05 ET | 8-K | 3.02 Unregistered sale of equity | 0000950170-25-096914 |
| 2025-07-0320:03 ET | 8-K | 3.01 Delisting notice | 0000950170-25-093832 |
| 2025-06-1621:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015282 |
| 2025-06-1320:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015065 |
| 2025-06-0920:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014296 |
| 2025-05-1420:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010252 |
| 2025-05-0520:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-008680 |
| 2025-04-2310:01 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-005760 |
| 2025-03-3120:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001691 |
| 2025-02-0722:24 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-005456 |
| 2025-01-2421:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-003571 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.